期刊文献+

主动脉夹层5年死亡率相关因素的Logistic回归分析 被引量:3

原文传递
导出
摘要 目的分析急性主动脉夹层(AD)5年死亡率相关的危险因素。方法随访分析111例AD住院患者的临床资料,对5年内死亡的相关因素进行单因素及多因素Logistic回归分析。结果111例主动脉夹层患者中A型主动脉夹层70例(63.06%),B型主动脉夹层41例(36.94%),年龄18~84(59.56±12.39)岁,男女性别比2.7:1,发病后5年死亡率34.23%,吸烟史为独立的危险因素,ACEI/ARB类药物治疗、手术或介入治疗为独立的保护因素。结论吸烟史为主动脉夹层远期预后的独立危险因素,ACEI/ARB类药物治疗和主动脉弓置换手术或腔内介入隔绝术为独立的保护因素;主动脉弓置换手术或腔内介入隔绝术是治疗主动脉夹层较为安全和有效的方法。
出处 《中国医师杂志》 CAS 2012年第12期1651-1653,共3页 Journal of Chinese Physician
  • 相关文献

参考文献10

  • 1明广华,张宇辉,吴海英,祖菲雅,张连娟,郑德裕,刘国仗,孙立忠,惠汝太.179例主动脉夹层患者的临床资料分析[J].中国循环杂志,2004,19(5):363-366. 被引量:58
  • 2王淑媛,张国新,侯松岩,赵楚敏.吸烟与主动脉夹层的相关性分析[J].吉林大学学报(医学版),2008,34(3):468-468. 被引量:4
  • 3景霞,许建英.吸烟对大鼠气道上皮细胞基质金属蛋白酶9表达的影响[J].中国呼吸与危重监护杂志,2009,8(3):220-223. 被引量:13
  • 4Ishii T, Asuwa N. Collagen and elastin degradation by matrix met- alloproteinases and tissue inhibitors of matrix metalloproteinase in aorta dissection. Hum Pathol, 2000,31 (6) :640-646.
  • 5Bertrand ME, Fox KM, Remme WJ, et al. Angiotensin-eonverting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revaseularization: a subgroup analysis of the EU- ROPA trial. Arch Cardiovasc Dis,2009,102(2) :89-96.
  • 6Verma S, Mamdani M, A1-Omran M, et al. Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: A population- based cohort study ( UMPIRE study results). J Am Soc Hypertens, 2007,1 (4) :286-294.
  • 7Turnbull F, Neal B, Pfeffer M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens, 2007,25 ( 5 ) :951-958.
  • 8Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation : a clinical review. J Hyper- tens, 2006,24(6) :983-991.
  • 9王春,谷天祥,房勤,喻磊,修宗谊,章志伟.急诊手术治疗Stanford A型主动脉夹层的近期疗效[J].中国急救医学,2011,31(6):530-533. 被引量:3
  • 10张喆,杨碧波.覆膜血管支架治疗DebakeyⅢ型主动脉夹层[J].中国微创外科杂志,2008,8(1):70-71. 被引量:14

二级参考文献25

  • 1姚婉贞,陈亚红.2004年欧洲呼吸学会年会慢性阻塞性肺疾病研究进展[J].中国呼吸与危重监护杂志,2004,3(6):413-415. 被引量:11
  • 2陈京霞,李淑兰.基质金属蛋白酶-9与呼吸道重塑[J].医学综述,2006,12(22):1353-1355. 被引量:6
  • 3Ward SA, Casaburi R. 21st century perspective on chronic obstructive pulmonary disease. Respiration,2001,68:557-561.
  • 4Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med, 1998,158:1945-1950.
  • 5Kang MJ, Oh YM, Lee JC, et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sei ,2003,18:821-827.
  • 6Doherty DE. Early detection and management of COPD. What you can do to reduce the impact of this disabling disease. Postgrad Med, 2002,111:41-53.
  • 7[1]Nienaber CA,Fattori R,Lund G,et al.Nonsurgical reconstruction of thoracic dissection by stent-graft placement.N Engl J Med,1999,340(20):1539-1545.
  • 8[2]Leurs LJ,Bell R,Degrieck Y,et al.Endovascular treatment of thoracic aortic disease:combined experience from the EUROSTAR and United King Thoracic Endograft registries.J Vasc Surg,2004,40:670-679.
  • 9[3]Wang ZG,Li C.Single-branch endograft for treating stanford type B aortic dissections with entry tears in proximity to the left subclavian artery.J Endovasc Ther,2005,12 (5):588-593.
  • 10[5]Eggebrecht H,Herold U,Kuhnt O,et al.Endovascular stent-graft treatment of aortic dissection:determinants of post-interventional outcome.Eur Heart J,2005,26 (5):489-497.

共引文献82

同被引文献17

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部